Genetic variant in a BaP-activated super-enhancer increases prostate cancer risk by promoting AhR-mediated FAM227A expression
Open Access
- 1 January 2024
- journal article
- research article
- Published by Journal of Biomedical Research in Journal of Biomedical Research
- Vol. 38 (2) , 149-14
Abstract
Genetic variants in super -enhancers (SEs) are increasingly implicated as a disease risk -driving mechanism. Previous studies have reported an associations between benzo[a]pyrene (BaP) exposure and some malignant tumor risk. Currently, it is unclear whether BaP is involved in the effect of genetic variants in SEs on prostate cancer risk, nor the associated intrinsic molecular mechanisms. In the current study, by using logistic regression analysis, we found that rs5750581T>C in 22q -SE was significantly associated with prostate cancer risk (odds ratio = 1.26, P = 7.61 x 10( -5) ). We also have found that the rs6001092T>G, in a high linkage disequilibrium with rs5750581T>C ( r(2) = 0.98), is located in a regulatory aryl hydrocarbon receptor (AhR) motif and may interact with the FAM227A promoter in further bioinformatics analysis. We then performed a series of functional and BaP acute exposure experiments to assess biological function of the genetic variant and the target gene. Biologically, the rs6001092-G allele strengthened the transcription factor binding affinity to AhR, thereby upregulating FAM227A , especially upon exposure to BaP, which induced the malignant phenotypes of prostate cancer. The current study highlights that AhR acts as an environmental sensor of BaP and is involved in the SE -mediated prostate cancer risk, which may provide new insights into the etiology of prostate cancer associated with the inherited SE variants under environmental stressors.Keywords
This publication has 34 references indexed in Scilit:
- Androgen receptors in hormone-dependent and castration-resistant prostate cancerPharmacology & Therapeutics, 2013
- NCBI’s Database of Genotypes and Phenotypes: dbGaPNucleic Acids Research, 2013
- Super-Enhancers in the Control of Cell Identity and DiseaseCell, 2013
- The Tumor Suppressor Kruppel-Like Factor 6 Is a Novel Aryl Hydrocarbon Receptor DNA Binding PartnerThe Journal of Pharmacology and Experimental Therapeutics, 2013
- Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in TunisiansJournal of Translational Medicine, 2013
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-EnhancersCell, 2013
- EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-IndependentScience, 2012
- Dietary Benzo[a]pyrene Intake from Meat and the Risk of Colorectal CancerCancer Epidemiology, Biomarkers & Prevention, 2010
- Ligand Selectivity and Gene Regulation by the Human Aryl Hydrocarbon Receptor in Transgenic MiceMolecular Pharmacology, 2009
- Genome-wide association study of prostate cancer identifies a second risk locus at 8q24Nature Genetics, 2007